130 related articles for article (PubMed ID: 9503605)
1. Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity.
Kataoka H; Tahara H; Watanabe T; Sugawara M; Ide T; Goto M; Furuichi Y; Sugimoto M
Differentiation; 1997 Dec; 62(4):203-11. PubMed ID: 9503605
[TBL] [Abstract][Full Text] [Related]
2. Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Okubo M; Tsurukubo Y; Higaki T; Kawabe T; Goto M; Murase T; Ide T; Furuichi Y; Sugimoto M
Cancer Genet Cytogenet; 2001 Aug; 129(1):30-4. PubMed ID: 11520562
[TBL] [Abstract][Full Text] [Related]
3. Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines.
Sugimoto M; Ide T; Goto M; Furuichi Y
Mech Ageing Dev; 1999 Feb; 107(1):51-60. PubMed ID: 10197788
[TBL] [Abstract][Full Text] [Related]
4. Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus.
Tahara H; Tokutake Y; Maeda S; Kataoka H; Watanabe T; Satoh M; Matsumoto T; Sugawara M; Ide T; Goto M; Furuichi Y; Sugimoto M
Oncogene; 1997 Oct; 15(16):1911-20. PubMed ID: 9365237
[TBL] [Abstract][Full Text] [Related]
5. In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Takahashi T; Kawabe T; Okazaki Y; Itoh C; Noda K; Tajima M; Satoh M; Goto M; Mitsui Y; Tahara H; Ide T; Furuichi Y; Sugimoto M
DNA Cell Biol; 2003 Nov; 22(11):727-35. PubMed ID: 14659045
[TBL] [Abstract][Full Text] [Related]
6. WRN gene and other genetic factors affecting immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Sugimoto M; Tahara H; Okubo M; Kobayashi T; Goto M; Ide T; Furuichi Y
Cancer Genet Cytogenet; 2004 Jul; 152(2):95-100. PubMed ID: 15262425
[TBL] [Abstract][Full Text] [Related]
7. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
Tosato G; Blaese RM; Yarchoan R
J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
[TBL] [Abstract][Full Text] [Related]
8. Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability.
Yamashita Y; Tsurumi T; Mori N; Kiyono T
Pathol Int; 2006 Nov; 56(11):659-67. PubMed ID: 17040288
[TBL] [Abstract][Full Text] [Related]
9. Sustained viral activity of epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines.
Jeon JP; Nam HY; Shim SM; Han BG
Mol Cells; 2009 Feb; 27(2):143-8. PubMed ID: 19277495
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
Lau YL; Shields JG; Levinsky RJ; Callard RE
Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
[TBL] [Abstract][Full Text] [Related]
11. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Sugimoto M; Tahara H; Ide T; Furuichi Y
Cancer Res; 2004 May; 64(10):3361-4. PubMed ID: 15150084
[TBL] [Abstract][Full Text] [Related]
12. Differential cytotoxicity of anticancer agents in pre- and post-immortal lymphoblastoid cell lines.
Sawada K; Noda K; Nakajima H; Shimbara N; Furuichi Y; Sugimoto M
Biol Pharm Bull; 2005 Jul; 28(7):1202-7. PubMed ID: 15997098
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of EBV-transformable human B lymphocyte populations.
Chan MA; Stein LD; Dosch HM; Sigal NH
J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 stimulates immunoglobulin secretion by Epstein-Barr virus (EBV)-activated tonsillar B cells, and by EBV-transformed lymphoblastoid B cell lines without increasing cell division.
Shields JG; Kotowicz K; Callard RE
Int J Clin Lab Res; 1992; 22(2):95-9. PubMed ID: 1324027
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of immortalized B-lymphoblastoid cell lines of keloid pedigree and its karyotype analysis].
Song M; Gao JH; Yan X; Liu XJ; Chen Y
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1760-2. PubMed ID: 17259115
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
Brown NA; Miller G
J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955
[TBL] [Abstract][Full Text] [Related]
17. Production of human monoclonal antibodies by the epstein-barr virus method.
Steinitz M
Methods Mol Biol; 2014; 1060():111-22. PubMed ID: 24037838
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls.
Ounanian A; Guilbert B; Seigneurin JM
Mech Ageing Dev; 1992 Mar; 63(1):105-16. PubMed ID: 1318479
[TBL] [Abstract][Full Text] [Related]
19. Establishment of EBV-Infected Lymphoblastoid Cell Lines.
Nagy N
Methods Mol Biol; 2017; 1532():57-64. PubMed ID: 27873266
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients.
Okada M; Goto M; Furuichi Y; Sugimoto M
Biol Pharm Bull; 1998 Mar; 21(3):235-9. PubMed ID: 9556152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
